Tara Lech/X
Jun 22, 2025, 09:42
Tara Lech: Treatment of VTE Does NOT End at Discharge!
Tara Lech, Systems Director of Anticoagulation Services at Beth Israel Lahey Health, shared a post on X:
“Treatment of VTE does NOT end at discharge! We need a clinical framework in place to follow patients and allow for early detection of post-VTE symptoms and patient-reported concerns that impact Quality of Life.
Learn more about this project here.”
Stay updated with Hemostasis Today.
-
Jun 1, 2026, 11:16Ocima Richard Draza: Postpartum Hemorrhage – A Practical Step-by-Step Management Guide
-
Jun 1, 2026, 10:57Kyungjun Lim: How Will Future Mars Colonies Manage Their Supply Chains?
-
May 31, 2026, 16:29José Antonio García Erce: Collaborative PBM Implementation in Transfusion Centers and Services
-
May 31, 2026, 16:22Vera Ignjatović: How Do We Rigorously Study These Drugs in Children to Understand Their True Benefits and Risks?
-
May 31, 2026, 16:21Ksenija Stach: Is This The Future of Lipid-Lowering Lherapy?
-
May 31, 2026, 15:42Antonio Greco: Balancing Bleeding and Thrombotic Risk After PCI
-
May 31, 2026, 15:41Eric Topol: Replication of Plasma p-tau217 Blood Test for Predicting Alzheimer’s Disease
-
May 31, 2026, 15:32ASH Invites Dynamic Members to Apply for 2027 Leadership and Committee Roles
-
May 31, 2026, 14:39Monique Gore-Massy: Redefining Lupus Innovation Through Patient Partnership